Atheon bio Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
6
Atheon bio General Information
Description
Operator of a biotechnology company intended to develop anti-tumor therapeutics for the treatment of cancer. The company develops treatments to regulate the TME as a way to overcome the limitations of existing anticancer drugs, enabling healthcare individuals to access antibody treatments for solid cancer.
Contact Information
Website
www.atheonbio.comCorporate Office
- 502, 3rd Building
- 15, Pangyo-ro 228beongil, Bundang-gu
- Seongnam, Gyeonggi
- South Korea
Corporate Office
- 502, 3rd Building
- 15, Pangyo-ro 228beongil, Bundang-gu
- Seongnam, Gyeonggi
- South Korea
Atheon bio Timeline
Atheon bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Accelerator/Incubator | Completed | Startup | ||||
| 5. Accelerator/Incubator | 21-May-2024 | Completed | Startup | |||
| 4. Early Stage VC | 21-Feb-2024 | Completed | Startup | |||
| 3. Accelerator/Incubator | 25-May-2023 | Completed | Startup | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Seed Round | 01-Sep-2022 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Atheon bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Atheon bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Atheon bio Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Johnson & Johnson Innovation - JLABS | Accelerator/Incubator | |||
| HLB Investment | Corporate Venture Capital | Minority | ||
| Genaxis (Korea) | Venture Capital | Minority | ||
| Myriad Life Sciences | Accelerator/Incubator | Minority | ||
| IBK Changgong | Accelerator/Incubator |
Atheon bio FAQs
-
When was Atheon bio founded?
Atheon bio was founded in 2022.
-
Where is Atheon bio headquartered?
Atheon bio is headquartered in Seongnam, South Korea.
-
What is the size of Atheon bio?
Atheon bio has 2 total employees.
-
What industry is Atheon bio in?
Atheon bio’s primary industry is Drug Discovery.
-
Is Atheon bio a private or public company?
Atheon bio is a Private company.
-
What is Atheon bio’s current revenue?
The current revenue for Atheon bio is .
-
How much funding has Atheon bio raised over time?
Atheon bio has raised $749K.
-
Who are Atheon bio’s investors?
Johnson & Johnson Innovation - JLABS, HLB Investment, Genaxis (Korea), Myriad Life Sciences, and IBK Changgong are 5 of 6 investors who have invested in Atheon bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
